1. Home
  2. BCDA vs GIGM Comparison

BCDA vs GIGM Comparison

Compare BCDA & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

HOLD

Current Price

$1.42

Market Cap

15.4M

Sector

Health Care

ML Signal

HOLD

GIGM

GigaMedia Limited

N/A

Current Price

$1.50

Market Cap

17.8M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BCDA
GIGM
Founded
N/A
1998
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
15.4M
17.8M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
BCDA
GIGM
Price
$1.42
$1.50
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
64.9K
5.2K
Earning Date
11-12-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,397,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.11
52 Week Low
$1.00
$1.38
52 Week High
$3.20
$1.89

Technical Indicators

Market Signals
Indicator
BCDA
GIGM
Relative Strength Index (RSI) 54.40 40.84
Support Level $1.32 $1.50
Resistance Level $1.34 $1.56
Average True Range (ATR) 0.07 0.04
MACD 0.02 0.00
Stochastic Oscillator 84.00 40.95

Price Performance

Historical Comparison
BCDA
GIGM

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About GIGM GigaMedia Limited

GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.

Share on Social Networks: